Advertisement

Biotechnology and Bioactive Polymers

  • Charles G. Gebelein
  • Charles E. CarraherJr.

Table of contents

  1. Front Matter
    Pages i-ix
  2. Polysaccharide Applications

    1. Charles E. Carraher Jr., Cynthia Butler, Yoshinobu Naoshima, Dorothy Sterling, Vincent Saurino
      Pages 1-8
    2. Victor J. Morris
      Pages 9-16
    3. A. W. Stemberger, F. Bader, S. Haas, J. M. Walenga, G. Blümel
      Pages 17-23
    4. Nancy E. Larsen, Cynthia T. Pollak, Karen Reiner, Edward Leshchiner, Endre A. Balazs
      Pages 25-33
    5. Shigehiro Hirano, Hiroshi Inui, Hideto Kosaki, Yoshitaka Uno, Tsuyoshi Toda
      Pages 43-54
    6. John F. Kennedy, Marion Paterson, David W. Taylor, Maria P. C. Silva
      Pages 55-69
    7. Charles E Carraher Jr., Dorothy C Sterling, Cynthia Butler, Thomas Ridgway
      Pages 71-77
  3. Polypeptides and Biodegradable Polymers

    1. Alastair Nicol, D. Channe Gowda, Timothy M. Parker, Dan W. Urry
      Pages 95-113
    2. Anthony J. Salerno, Ina Goldberg
      Pages 115-126
    3. A. Stemberger, R. Ascherl, M. A. Scherer, F. Bader, W. Erhardt, B. C. Adelmann-Grill et al.
      Pages 127-133
    4. Alok Singh, Michael A. Markowitz, Li-I Tsao
      Pages 135-146
  4. Medical Diagnostic Applications

    1. A. F. Azhar, A. D. Burke, J. E. DuBois, A. M. Usmani
      Pages 177-183
    2. J. E. Kennamer, A. D. Burke, A. M. Usmani
      Pages 195-200
    3. Rikio Tsushima, Akihiro Kondo, Masaru Sakata, Nariyoshi Kawabata
      Pages 201-206
    4. Yoshiaki Inaki, Kenji Matsukawa, Kiichi Takemoto
      Pages 207-223
  5. Controlled Release and Medicinal Applications

    1. E. Schmitt, D. R. Flanagan, R. J. Linhardt
      Pages 249-258
    2. Robert J. Levy, Gershon Golomb, Joseph Trachy, Vinod Labhasetwar, David Muller, Eric Topol
      Pages 259-268
    3. Hilton Levy, Andres Salazar, Javier Morales, Owen St. Clair Morgan
      Pages 269-276
    4. Charles G. Gebelein, Darrell Williams, Kathy Marshall, Terri Slaven
      Pages 277-288
    5. Charles E. Carraher Jr., Daniel S. Powers, Bhoomin Pandya
      Pages 297-308
    6. Charles G. Gebelein, Donna Gardner, Tonya Ellis
      Pages 309-316
    7. W. Kohnen, B. Jansen, D. Ruiten, H. Steinhauser, G. Pulverer
      Pages 317-325
  6. Back Matter
    Pages 327-342

About this book

Introduction

Some have predicted that the coming several decades will be the decades of "biotechnology," wherein cancer, birth defects, life span increases, cosmetics, biodegradation, oil spills and exploration, solid waste disposal, and almost every aspect of our material life will be affected by this new area of science. There will also be an extension of emphasis on giant molecules: DNA, enzymes, polysaccharides, lignins, proteins, hemoglobin, and many others. Biotechnology has been defined in various ways. In one sense, this field is older than human history and references to the human use of biotechnology-derived materials can be found in the oldest human writings, such as the Bible. In this book, biotechnology refers to the direct usage of naturally occurring materials or their uses as a feedstock, including the associated biological activities and applications of these materials. Bioactive polymers, on the other hand, are polymers which exert some type of activity on living organisms. These polymers are used in agriculture, controlled release systems, medicine and many other areas. The papers in this book describe polymers which essentially combine features of biotechnology and bioactivity.

Keywords

DNA Heparin Lignin Polysaccharid enzymes polymer proteins

Editors and affiliations

  • Charles G. Gebelein
    • 1
    • 2
  • Charles E. CarraherJr.
    • 2
  1. 1.Lionfire, Inc.EdgewaterUSA
  2. 2.Florida Atlantic UniversityBoca RatonUSA

Bibliographic information

Industry Sectors
Pharma
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods